In today’s ACT Brief, we examine why the future of AI in trials is a trusted orchestration system rather than a single model, how coordinators rate eSource-enabled workflows, and what a bipartisan bill proposes for reusable trial networks.
|Articles|March 22, 2017
Oracle Health Expands Data Management to Cloud
Advertisement
Speeds Clinical Discoveries and Reduces Research Costs
Orlando, FL - Oracle Health Sciences today unveiled Data Management Workbench Cloud Service that promises to lower the cost and increase traceability of clinical development by streamlining end to end clinical data flow across Clinical R&D.
Planning and managing clinical trials has become more complex as additional data is being generated, collected and analyzed to demonstrate clinical efficacy, ensure successful regulatory approval and ultimately bring more therapies to market faster. Oracle Health Sciences Data Management Workbench Cloud Service enables pharmaceutical companies and contract research organizations to integrate, reconcile and analyze the growing variety and volume of clinical and healthcare data. By automating data flow and standardizing data for review, clinical researchers have near real time access to insights for clinical trial decision making – all at a dramatically lower total cost of ownership as a result of it being offered as a cloud service.
“The volume and complexity of data in healthcare and life sciences has increased on a massive scale as we capture more data from sources such as electronic health records, wearables and genomics. Clinical data managers and data scientists are now integrating more of this data into their clinical research and trials to improve the odds of more therapies making it to market and faster,” said Steve Rosenberg, general manager, Oracle Health Sciences. “The industry has been looking for a purpose-built data management solution that supports the clinical data flow from source to submission, with a lightweight, cloud-based solution, and Oracle’s new cloud-based data management platform is able to manage all of this new information while ensuring FDA data compliance – at a dramatically lower cost.”
Oracle Data Management Workbench Cloud Service is pre-integrated with Oracle Health Sciences InForm, enabling two-way real time data flow. Additionally, it brings new levels of standardization, reusability and traceability among disparate clinical data sources by enabling clinical data managers to aggregate, clean and transform data into submission-ready deliverables more quickly than ever before. By using an integrated workflow, data discrepancies can be closed faster, reducing clinical review cycle times and increasing overall data quality.
Additional Resources
Oracle Health Sciences Data Management Workbench
Oracle Health Sciences Twitter:
About Oracle
Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle, visit
Advertisement
Related to this article
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Syneos Health and Optum outline a joint model for trial planning, recruitment and site access, with no financial terms or timelines disclosed.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
2
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
3
Bipartisan Bill Would Build Reusable Clinical Trial Networks, With a Focus on Rare Disease
4
Where AI Governance in Clinical Development Falls Short
5